The Mediterranean Zone (36 page)

Rahman I, Biswas SK, and Kirkham PA. “Regulation of inflammation and redox signaling by dietary polyphenols.” Biochem Pharmacol 72: 1439–1452 (2006)

Rizzo AM, Montorfano G, Negroni M, Adorni L, Berselli P, Corsetto P, Wahle K, and Berra B. “A rapid method for determining arachidonic: eicosapentaenoic acid ratios in whole blood lipids: correlation with erythrocyte membrane ratios and validation in a large Italian population of various ages and pathologies.” Lipids Health Dis 9: 7 (2010)

Sanchez-Galan E, Gomez-Hernandez A, Vidal C, Martin-Ventura JL, Blanco-Colio LM, Munoz-Garcia B, Ortega L, Egido J, and Tunon J. “Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis.” Cardiovasc Res 81: 216–225 (2009)

Scapagnini G, Vasto S, Sonya V, Abraham NG, Nader AG, Caruso C, Calogero C, Zella D, and Fabio G. “Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders.” Mol Neurobiol 44: 192–201 (2011)

Schmitz G and Ecker J. “The opposing effect of n-3 and n-6 fatty acids.” Prog Lipid Res 47: 147–155 (2008)

Sears, B.
The Zone.
Regan Books. New York, NY (1995)

Sears, B.
The Anti-Aging Zone
. Regan Books. New York, NY (1999)

Sears, B.
The OmegaRx Zone
. Regan Books. New York, NY (2002)

Sears, B.
The Anti-Inflammation Zone
. Regan Books. New York, NY (2005)

Sears, B.
Toxic Fat
. Thomas Nelson. Nashville, TN. (2008)

Sears B and Ricordi C. “Role of fatty acids and polyphenols in inflammatory gene transcription and their impact on obesity, metabolic syndrome and diabetes.” Eur Rev Med Pharmacol Sci 16: 1137–1154 (2012)

Sears DD, Miles PD, Chapman J, Ofrecio JM, Almazan F, Thapar D, and Miller YI. “12/15-lipoxygenase is required for the early onset of high fat diet-induced adipose tissue inflammation and insulin resistance in mice.” PLoS ONE 4: e7250 (2009)

Stillwell W and Wassall SR. “Docosahexaenoic acid: membrane properties of a unique fatty acid.” Chem Phys Lipids 126: 1–27 (2003)

Tall AR. “C-reactive protein reassessed.” N Engl J Med 350: 1450–1452 (2004)

Umhau JC, Zhou W, Carson RE, Rapoport SI, Polozova A, Demar J, Hussein N, Bhattacharjee AK, Ma K, Esposito G, Majchrzak S, Herscovitch P, Eckelman WC, Kurdziel KA, and Salem N. “Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography.” J Lipid Res 50: 1259–1268 (2009)

Zhang MJ and Spite M. “Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids.” Annu Rev Nutr 32: 203–227 (2012)

Ailhaud G, Guesnet P, and Cunnane SC. “An emerging risk factor for obesity: does disequilibrium of polyunsaturated fatty acid metabolism contribute to excessive adipose tissue development?” Br J Nutr 100: 461–470 (2008)

Ailhaud G. “Omega-6 fatty acids and excessive adipose tissue development.” World Rev Nutr Diet 98: 51–61 (2008)

Alvheim AR, Malde MK, Osei-Hyiaman D, Lin YH, Pawlosky RJ, Madsen L, Kristiansen K, Froyland L, and Hibbeln JR. “Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity.” Obesity 10: 1984–1994 (2012)

Alvheim AR, Torstensen BE, Lin YH, Lillefosse HH, Lock EJ, Madsen L, Froyland L, Hibbeln JR, and Malde MK. “Dietary linoleic acid elevates the endocannabinoids 2-AG and anandamide and promotes weight gain in mice fed a low fat diet.” Lipids 49: 59–69 (2014)

Batterham RL, Heffron H, Kapoor S, Chivers JE, Chandarana K, Herzon H, le Roux CW, Thomas EL, Bell JD, and Withers DJ. “Critical role for peptide YY in protein-mediated satiation and body-weight regulation.” Cell Metabol 4: 223–233 (2006)

Benhamed F, Poupeau A, and Postic C. “The transcription factor ChREBP: a key modulator of insulin sensitivity?” Med Sci 29: 765–771 (2013)

Beglinger C and Degen L. “Gastrointestinal satiety signals in humans—physiologic roles for GLP-1 and PYY?” Physiol Behav 89: 460–464 (2006)

Berg JM, Tymoczko JL, and Stryer L.
Biochemistry, 5th edition
. W.H. Freeman. New York, NY (2002)

Bilsborough S and Mann N. “A review of issues of dietary protein intake in humans.” Int J Sport Nutr Exerc Metab 16: 129–152 (2006)

Buckland G. Bach A. and Serra-Majem L. “Obesity and the Mediterranean diet: a systematic review of observational and intervention studies.” Obes Rev 9: 582–593 (2008)

Cai D. “Neuroinflammation and neurodegeneration in overnutrition-induced diseases.” Trends Endocrinol Metab 24: 40–47 (2013)

Chaudhri OB, Field BC, and Bloom SR. “Gastrointestinal satiety signals.” Int J Obes 7: S28–31 (2008)

Claria J, Dalli J, Yacoubian S, Gao F, and Serhan CN. “Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat.” J Immunology 189: 2597–2605 (2012)

Cole BK, Lieb DC, Dobrian AD, and Nadler JL. “12- and −15 lipoxygenases in adipose tissue inflammation.” Prostaglandins and Other Lipid Mediators 105: 84–92 (2013)

Czech MP, Tencerova M, Pedersen DJ, and Aouadi M. “Insulin signaling mechanisms for triacylglycerol storage.” Diabetologia 56: 949–964 (2013)

Dentin R, Denechaud P-D, Benhamed F, Girad J, and Postic C. “Hepatic gene regulation by glucose and polyunsaturated fatty acids: a role for ChREBP.” J Nutr 136: 1145–1149 (2006)

Dockray GJ. “Cholecystokinin.” Curr Opin Endocrinol Diabetes Obes 19: 8–12 (2012)

Ebbeling CB, Swain JF, Feldman HA, Wong WW, Hachey DL, Garcia-Lago E, and Ludwig DS. “Effects of dietary composition on energy expenditure during weight-loss maintenance.” JAMA 307: 2627–2634 (2012)

Flachs P, Horakova O, Brauner P, Rossmeisl M, Pecina P, Franssen-van Hal N,
Ruzickova J, Sponarova J, Drahota Z, Vlcek C, Keijer J, Houstek J, and Kopecky J. “Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat.” Diabetologia 48: 2365–2375 (2005)

Gonzalex-Periz A, Horrillo R, Ferre N, Gronert K, Dong B, Moran-Salvador E, Titos E, Martinez-Clemente M, Lopez-Parra M, Arroyo V, and Claria J. “Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins.” FASEB J 23: 1946–1957 (2009)

Gregor MF and Hotamisligil GS. “Inflammatory mechanisms in obesity.” Ann Rev Immunol 29: 415–445 (2011)

Hanbauer I, Rivero-Covelo I, Maloku E, Baca A, Hu Q, Hibbeln JR, and Davis JM. “The decrease of n-3 fatty acid energy percentage in an equicaloric diet fed to B6C3Fe mice for three generations elicits obesity.” Cardiovasc Psychiatry Neurol 2009: 867041 (2009)

Itariu BK, Zeyda M, Hochbrugger EE, Neuhofer A, Prager G, Schindler K; Bohdjalian A, Mascher D, Vangala S, Schranz M, Krebs M, Bischof MG, and Stulnig TM. “Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial.” Am J Clin Nutr 96: 1137–1149 (2012)

Jin C and Flavell RA. “Innate sensors of pathogen and stress: linking inflammation to obesity.” J Allergy Clin Immunol 132: 287–294 (2013)

Jornayvaz FR, Jurczak MJ, Lee HY, Birkenfeld AL, Frederick DW, Zhang D, Zhang XM, Samuel VT, and Shulman GI. “A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain.” Am J Physiol Endocrinol Metab. 299: E808–15 (2010)

Kim J, Li Y, and Watkins BA. “Fat to treat fat: emerging relationship between dietary PUFA, endocannabinoids, and obesity.” Prostaglandins Other Lipid Mediators 105: 32–41 (2013)

Kirkham TC. “Endocannabinoids and the non-homeostatic control of appetite.” Curr Top Behav Neurosci 1: 231–253 (2009)

Lafontan M and Langin D. “Lipolysis and lipid mobilization in human adipose tissue.” Prog Lipid Res. 48: 275–297 (2009)

le Roux CW, Batterham RL, Aylwin SJLB, Patterson, Borg Cm, Wynee KJ, Kent A, Vincent RP, Gardiner J, Ghati MA, and Bloom SR. “Attenuated peptide YY release inobese subjects is associated with reduced satiety.” Endocrinology 147: 3–8 (2006)

Lennerz BS, Alsop DC, Holsen LM, Stern E, Rojas R, Ebbeling CB, Goldstein JM, and Ludwig DS. “Effects of dietary glycemic index on brain regions related to reward and craving in men.” Am J Clin Nutr 98: 641–647 (2013)

Lumrn CN and Saltiel AR. “Inflammatory links between obesity and metabolic disease.” J Clin Invest 121: 2111–2117 (2011)

Massiera F, Saint-Marc P, Seydoux J, Murata T, Kobayashi T, Narumiya S, Guesnet P, Amri EZ, Negrel R, and Ailhaud G. “Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern?” J Lipid Res 44: 271–279 (2003)

Murphy KG and Bloom SR. “Gut hormones and the regulation of energy homeostatsis.” Nature 444: 854–858 (2006)

Neuhofer A, Zeyda M, Mascher D, Itariu BK, Murano I, Leitner L, Hochbrugger EE,
Fraisl P, Cinti S, Serhan CN, and Stulnig TM. “Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation.” Diabetes 62: 1945–1956 (2013)

Padwal RS, Pajewski NM, Allison DB, and Sharma AM. “Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity.” CMAJ 183: E1059–1066 (2011)

Porte D, Baskin DG, and Schwartz MW. “Leptin and insulin action in the central nervous system.” Nutr Rev 60: S20–9 (2002)

Parks BW, Nam E, Org E, Kostem E, Norheim F, Hui ST, Pan C, Civelek M, Rau CD, Bennett BJ, Mehrabian M, Ursell LK, He A, Castellani LW, Zinker B, Kirby M, Drake TA, Drevon CA, Knight R, Gargalovic P, Kirchgessner T, Eskin E, and Lusis AJ. “Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice.” Cell Metab 17: 141–152 (2013)

Postic C, Dentin R, Denechaud PD, and Girard J. “ChREBP, a transcriptional regulator of glucose and lipid metabolism.” Annu Rev Nutr 27: 179–192 (2007)

Ramel PD, Bandarra N, Kiely M, Marinez JA, and Thorsdottir I. “A diet rich in long chain omega-3 fatty acids modulates satiety in overweight and obese volunteers during weight loss.” Appetite 51: 676–680 (2008)

Ribet C, Montastier E, Valle C, Bezaire V, Mazzucotelli A, Mairal A, Viguerie N, and Langin D. “Peroxisome proliferator-activated receptor-alpha control of lipid and glucose metabolism in human white adipocytes.” Endocrinology 151: 123–133 (2010)

Reilly SM and Satiel AR. “Obesity: A complex role for adipose tissue macrophages.” Nat Rev Endocrin 10: 193–194 (2014)

Sadur CN and Eckel RH. “Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycemic clamp technique.” J Clin Invest 69: 1119–1125 (1982)

Saltzman E and Karl JP. “Nutrient deficiencies after gastric bypass surgery.” Annu Rev Nutr 33: 183–203 (2013)

Schwartz MW and Morton GJ. “Keeping hunger at bay.” Nature 418: 595–597 (2002)

Sears B.
Toxic Fat.
Thomas Nelson. Nashville, TN. (2008)

Soria-Gómez E, Bellocchio L, Reguero L, Lepousez G, Martin C, Bendahmane M, Ruehle S, Remmers F, Desprez T, Matias I, Wiesner T, Cannich A, Nissant A, Wadleigh A, Pape HC, Chiarlone AP, Quarta C, Verrier D, Vincent P, Massa F, Lutz B, Guzmán M, Gurden H, Ferreira G, Lledo PM, Grandes P, and Marsicano G. “The endocannabinoid system controls food intake via olfactory processes.” Nat Neurosci 17: 407–415 (2014)

Storlien L, Oakes ND, and Kelley DE. “Metabolic flexibility.” Proc Nutr Soc 63: 363–368 (2004)

Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, and Proietto J. “Long-term persistence of hormonal adaptations to weight loss.” N Engl J Med 365: 1597–1604 (2011)

Thaler JP and Schwartz MW. “Minireview: Inflammation and obesity pathogenesis: the hypothalamus heats up.” Endocrinology 151: 4109–4115 (2010)

Thomas JG, Bond DS, Phelan S, Hill JO, and Wing RR. “Weight-loss maintenance for 10 years in the National Weight Control Registry.” Am J Prev Med 46: 17–23 (2014)

Titos E and Claria J. “Omega-3-derived mediators counteract obesity-induced adipose tissue inflammation.” Prostaglandins Other Lipid Mediators 107: 77–84 (2013)

Todoric J, Loffler M, Huber J, Bilban M, Reimers M, Kadl A, Zeyda M, Waldhausl W, and Stulnig TM. “Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids.” Diabetologia 49: 2109–2119 (2006)

Unger RH. “Lipotoxic diseases.” Annu Rev Med 53: 319–336 (2002)

Veldhorst M, Smeets A, Soenen S, Hochstenbach-Waelen A, Hursel R, Diepvens K, Lejeune M, Luscombe-Marsh N, and Westerterp-Plantenga M. “Protein-induced satiety: effects and mechanisms of different proteins.” Physiol Behav 94: 300–307 (2008)

Vincent RP and le Roux CW. “Changes in gut hormones after bariatric surgery.” Clin Endocrinol 69: 173–179 (2008)

Arbo I, Halle C, Malik D, Brattbakk HR, and Johansen B. “Insulin induces fatty acid desaturase expression in human monocytes.”Scand J Clin Lab Invest 71: 330–339 (2011)

Baylin A and Campos H. “Arachidonic acid in adipose tissue is associated with nonfatal acute myocardial infarction in the central valley of Costa Rica.” J Nutr. 134: 3095–3099 (2004)

Brenner RR. “Hormonal modulation of delta-6 and delta-5 desaturases: case of diabetes.” Prostaglandins Leukot Essent Fatty Acids 68: 151–162 (2003)

Cawood AL, Ding R, Napper FL, Young RH, Williams JA, Ward MJ, Gudmundsen O, Vige R, Payne SP, Ye S, Shearman CP, Gallagher PJ, Grimble RF, and Calder PC. “Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability.” Atherosclerosis 212: 252–259 (2010)

el Boustani S, Causse JE, Descomps B, Monnier L, Mendy F, and Crastes de Paulet A. “Direct in vivo characterization of delta 5 desaturase activity in humans by deuterium labeling: effect of insulin.” Metabolism 38: 315–321 (1989)

Glass CK and Olefsky JM. “Inflammation and lipid signaling in the etiology of insulin resistance.” Cell Metab. 15: 635–645 (2012)

Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C, and Kaidi A. “The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment.” Carcinogenesis 30: 377–386 (2009)